These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27904915)

  • 1. Studies using a porcine model: what insights into human calcium oxalate stone formation mechanisms has this model facilitated?
    Penniston KL; Patel SR; Schwahn DJ; Nakada SY
    Urolithiasis; 2017 Feb; 45(1):109-125. PubMed ID: 27904915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A porcine model of calcium oxalate kidney stone disease.
    Mandel NS; Henderson JD; Hung LY; Wille DF; Wiessner JH
    J Urol; 2004 Mar; 171(3):1301-3. PubMed ID: 14767337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Handling of Oxalate in the Body and the Origin of Oxalate in Calcium Oxalate Stones.
    Huang Y; Zhang YH; Chi ZP; Huang R; Huang H; Liu G; Zhang Y; Yang H; Lin J; Yang T; Cao SZ
    Urol Int; 2020; 104(3-4):167-176. PubMed ID: 31805567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new model of nephrolithiasis involving tubular dysfunction/injury.
    Kumar S; Sigmon D; Miller T; Carpenter B; Khan S; Malhotra R; Scheid C; Menon M
    J Urol; 1991 Nov; 146(5):1384-9. PubMed ID: 1942307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model.
    Kaplon DM; Penniston KL; Darriet C; Crenshaw TD; Nakada SY
    J Endourol; 2010 Mar; 24(3):355-9. PubMed ID: 20078233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric acid-related nephrolithiasis.
    Low RK; Stoller ML
    Urol Clin North Am; 1997 Feb; 24(1):135-48. PubMed ID: 9048857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of dietary oxalate on kidney stone formation.
    Holmes RP; Assimos DG
    Urol Res; 2004 Oct; 32(5):311-6. PubMed ID: 15221245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sex hormones in experimental calcium oxalate nephrolithiasis.
    Fan J; Chandhoke PS; Grampsas SA
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S376-80. PubMed ID: 10541267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
    Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
    Berland Y
    Nephrologie; 1999; 20(7):363-9. PubMed ID: 10642984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].
    Dumoulin G; Haton D; Wolf JP; Henriet MT; Nguyen NU; Mougin C; Saint-Hillier Y; Combes M; Berthelay S
    Nephrologie; 1984; 5(5):189-91. PubMed ID: 6531054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of renal calculi.
    Miller NL; Evan AP; Lingeman JE
    Urol Clin North Am; 2007 Aug; 34(3):295-313. PubMed ID: 17678981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.